IOBTQ · IO Biotech, Inc. · Financials
Substantial doubt about the company's ability to continue as a going concern.
“Our recurring losses from operations raise substantial doubt about our ability to continue as a going concern. As a result, the financial statements accompanying this Quarterly Report on Form 10-Q include a statement that there is substantial doubt about our ability to continue as a going concern for one year after the date the financial statements were issued, and these financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result from the outcome of this uncertainty.”View the 10-Q filed Nov 14, 2025
Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.
Chart any reported metric, KPI or segment over time — the full statement history lives here
| Line Item | TTM | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| $67.92M | $71.48M | $67.83M | $46.99M | $30.15M | $8.46M | |
| $24.14M | $23.69M | $23.61M | $24.44M | $11.08M | $1.68M | |
| $300K | $300K | $200K | $100K | $0 | — | |
| $92.05M | $95.18M | $91.44M | $71.42M | $41.23M | $10.15M | |
| -$92.05M | -$95.18M | -$91.44M | -$71.42M | -$41.23M | -$10.15M | |
| — | — | — | $302K | $361K | $26K | |
| $2.75M | $1.13M | $6.21M | $1.24M | -$26.58M | -$1.9M | |
| -$89.3M | -$94.05M | -$85.23M | -$70.19M | -$67.81M | -$12.04M | |
| -$955K | $1.44M | $852K | $1.27M | $68K | — | |
| -$88.36M | -$95.5M | -$86.08M | -$71.46M | -$67.88M | -$12.04M | |
| -$88.35M | -$95.49M | -$86.08M | -$71.46M | -$74.99M | -$14.59M | |
| -$84.51M | -$92.67M | -$85.61M | -$80.11M | -$71.33M | -$11.38M | |
| USD/shares | -$1.35 | -$1.45 | -$1.98 | -$2.48 | -$17.30 | — |
| USD/shares | -$1.35 | -$1.45 | -$1.98 | -$2.48 | -$17.30 | — |
| shares | — | 65.88M | 43.54M | 28.82M | 4.34M | 177.2K |
| shares | — | 65.88M | 43.54M | 28.82M | 4.34M | 177.2K |
Debt Profile
Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.
Reported debt balances
Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.
| Reported balance | As of | Amount | Source |
|---|---|---|---|
| Current operating lease liabilities | 2025-09-30 | USD 788,000 | 10-Q filed 2025-11-14 |
| Noncurrent debt carrying amount | 2025-09-30 | USD 16,664,000 | 10-Q filed 2025-11-14 |
| Noncurrent operating lease liabilities | 2025-09-30 | USD 667,000 | 10-Q filed 2025-11-14 |
Covenants
Covenant terms have not yet been verified for this profile.
The balance figures do not establish whether covenants apply or whether the company complies with them.
Loans, facilities and notes
The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.